Eu Ivdd Eu Ivd Annex 2 List B On The Market 🇹🇼 Taiwan

Wellion AMADEUS

Apex Biotechnology Corp. · 🇹🇼 Taiwan
Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
D-47136487603C3SY3
Basic UDI-DI Code
B-47136487603C3SY3
Reference
S5800475, S5800476, S5800477
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List B
Status
On The Market

Additional Description

The purpose of the control solution test is to validate the performance of the blood glucose monitoring system. There are 2-3 different levels of control solution. Each has a different concentration of glucose, allowing you to check for test result accracy at low, normal and high glucose levels for any given batch of test strips. Results that are within the specified glucose concentration ranges confirm that the user's technique is appropriate and that the test strip and the meter are functioning properly. The blood glucose monitoring system used together with the control solution is plasma calibrated.

CND Nomenclature Codes

Code Description
W010106010801 BLOOD TEST STRIPS CONTROLS

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) HL2100077-1

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).

View all